Monday, September 10, 2018

Misleading Cancer Chemotherapy Headline


Oh the annoyance of social media...

I saw this posted on Facebook.
The headline is highly misleading and seems to pander to quackery lovers. If one reads the study it does not say that it was half at all.

The actual numbers:
30-day mortality was 8.47% for patients with lung cancer (1274/15045)
2.47% for patients with breast cancer (700/28364)

30-day mortality for patients receiving palliative treatment 10% for lung cancer (1061/10587)
 7.48% for breast cancer (569/7602),
 30-day mortality for patients receiving curative treatment 2.88% for lung cancer (70/2429)
 0.26% for breast cancer (41/15626)

This study was with people who are in palliative care. The study also showed the difference in people (in palliative care) who were using it for the first time as opposed to those who have already been using it (hint...those who have already been using SACT (systemic anti-cancer therapy ) lived longer statistically speaking). It did not compare to those without SACT.

According to Dr. David Dodwell, one of the authors of the study "Simply reducing doses of or avoiding SACT altogether would reduce or eliminate instances of treatment-related early mortality, but at the cost of some patients being denied effective SACT and hence the survival and palliation benefits. In order to maximise the benefits of systemic treatment, it is important to gain a detailed understanding of how many different factors affecting patients are linked to the increased risk of early mortality."  Therefore the conclusion is not to use chemotherapy but to find all the factors that will help during palliative care.

This website that has this article with the misleading headline is also a quack site and is not reputable. Linking to it just gives misleading information.

No comments:

Post a Comment